FLUOCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
When do Fluocinolone Acetonide patents expire, and when can generic versions of Fluocinolone Acetonide launch?
Fluocinolone Acetonide is a drug marketed by Allied, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Invatech, Perrigo New York, Pharmafair, Taro, Usl Pharma, Amneal, Lyne, Padagis Israel, Quagen, Sciegen Pharms Inc, Trupharma, Novel Labs Inc, Pharmaderm, Actavis Labs Ut Inc, Bausch And Lomb, Chartwell Rx, Encube Ethicals, Lupin, and Pai Holdings Pharm. and is included in fifty-five NDAs.
The generic ingredient in FLUOCINOLONE ACETONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluocinolone Acetonide
A generic version of FLUOCINOLONE ACETONIDE was approved as fluocinolone acetonide by TARO on April 27th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUOCINOLONE ACETONIDE?
- What are the global sales for FLUOCINOLONE ACETONIDE?
- What is Average Wholesale Price for FLUOCINOLONE ACETONIDE?
Summary for FLUOCINOLONE ACETONIDE
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 55 |
| Finished Product Suppliers / Packagers: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 33 |
| Patent Applications: | 4,586 |
| Drug Prices: | Drug price information for FLUOCINOLONE ACETONIDE |
| What excipients (inactive ingredients) are in FLUOCINOLONE ACETONIDE? | FLUOCINOLONE ACETONIDE excipients list |
| DailyMed Link: | FLUOCINOLONE ACETONIDE at DailyMed |
Recent Clinical Trials for FLUOCINOLONE ACETONIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Eye Institute (NEI) | Phase 3 |
| Jaeb Center for Health Research | Phase 3 |
| Genentech, Inc. | Phase 3 |
Pharmacology for FLUOCINOLONE ACETONIDE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for FLUOCINOLONE ACETONIDE
Anatomical Therapeutic Chemical (ATC) Classes for FLUOCINOLONE ACETONIDE
US Patents and Regulatory Information for FLUOCINOLONE ACETONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OINTMENT;TOPICAL | 088507-001 | Feb 27, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Israel | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OIL;TOPICAL | 202848-001 | Aug 9, 2013 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cosette | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | SOLUTION;TOPICAL | 207441-001 | Sep 28, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
